IP Library › Granted Patent US 10,537,689
Granted Patent B2
US 10,537,689 · App. 16/158,808 · Granted Jan 21, 2020

Delivery system

Inventors: James J. Yoo (Winston-Salem, NC); Anthony Atala (Winston-Salem, NC); Kyle W. Binder (Winston-Salem, NC); Mohammad Z. Albanna (Winston-Salem, NC); Weixin Zhao (Winston-Salem, NC); Dennis Dice (Yadkinville, NC); Tao Xu (El Paso, TX)
Assignee: Wake Forest University Health Sciences
A61M11/00A61B5/0064A61B5/1077A61B5/1079A61B5/445A61B5/6835A61L27/225A61L27/24A61L27/3813A61L27/60A61M35/00C12N5/0656A61B34/30A61B90/50A61B2017/00969A61B2017/3225A61B2034/105B41J3/4073
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,537,689
App. No.
16/158,808
Granted
Jan 21, 2020
Kind
B2
Abstract

Provided herein is a delivery system, including: (a) an optical sensor configured to detect data to create a map of a patient bodily surface; and (b) a dispenser operatively associated with the optical sensor and configured to deliver compositions (optionally including cells) to the patient bodily surface based upon the data or map. Methods of forming a tissue on a patient bodily surface of a patient in need thereof are also provided, as are methods, systems and computer program products useful for processing patient bodily surface data.

Claims (22)

1. A delivery system for forming skin tissue on a patient bodily surface, said delivery system comprising:

(a) an optical detector configured to detect data to create a map of said patient bodily surface, which optical detector further comprises a depth detector, operatively associated with said optical detector, to account for movement of said patient during said detection, wherein said optical detector comprises a three-dimensional scanner;

(b) a dispenser operatively associated with said optical detector and configured to deliver cells and/or compositions to said patient bodily surface based upon said data or said map;

(c) a three-dimensional plotter operatively connected with said three-dimensional scanner; and

(d) a controller operatively connected with said dispenser.

2. The delivery system of claim 1 , wherein said depth detector comprises an infrared detector.

3. The delivery system of claim 1 , wherein said three-dimensional scanner is a laser scanner.

4. The delivery system of claim 1 , wherein said three-dimensional scanner is a hand-held laser scanner.

5. The delivery system of claim 1 , wherein said dispenser comprises a plurality of nozzles.

6. The delivery system of claim 5 , further comprising one or more cartridges loaded with a composition, said composition optionally comprising cells,

wherein said nozzles are in fluid communication with said one or more cartridges.

7. The delivery system of claim 6 , wherein said nozzles are configured for pressure-based delivery of the compositions.

8. The delivery system of claim 6 , wherein said cells are amniotic fluid stem cells.

9. The delivery system of claim 6 , wherein said cells are skin cells.

10. The delivery system of claim 9 , wherein said cells are autologous.

11. The delivery system of claim 6 , wherein said cells are autologous.

12. The delivery system of claim 8 , wherein said cells are autologous.

13. The delivery system of claim 1 , further comprising:

means for interpreting the data of the patient bodily surface from said optical detector to form a model of the patient bodily surface;

means for transforming said model into a negative mold of the patient bodily surface, which mold is split into a plurality of Z-axis layers, which layers may optionally correspond to one or more tissue layers; and

means for overlaying each of said layers with a series of lines which represent coverage of the patient bodily surface, wherein said lines provide a path for the dispenser.

14. The delivery system of claim 13 , wherein the data of the patient bodily surface is wound surface data.

Continuity (5)
Division 14019714 · Sep 6, 2013
Continuation PCTUS2012027731 · Mar 5, 2012
Provisional Application 61507416 · Jul 13, 2011
Provisional Application 61450021 · Mar 7, 2011
Related Publication 20190038849A1 · Feb 7, 2019
Cited By (1)
US 12,268,467